Extensive Stage Small Cell Lung Cancer
Conditions
Interventions
Extensive-stage small cell lung cancer observation group:None
Sponsors
Hunan Provincial People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients whose histopathology clearly indicates SLCL and who have not received surgical treatment; 2. The clinical stage is extensive, with an ECOG score of 0-1. 3. The patient has undergone at least four cycles of platinum-based chemoradiotherapy combined with immunotherapy. 4. All clinical and follow-up data, imaging evaluations, and hematological indicators are complete
Exclusion criteria
Exclusion criteria: 1. Recurrent patients; 2. Patients with active systemic inflammation; 3. There is clear evidence of acute or chronic infection before treatment; 4. Patients with concurrent immune diseases and other malignant tumors; 5. Patients with severe heart, liver or kidney dysfunction; 6. Patients who need long-term systemic sex hormones; 7. Patients who have undergone four to six cycles of treatment and developed granulocytopenia and thrombocytopenia, or who have used white blood cell boosting injections and platelet boosting drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutrophil-to-lymphocyte ratio;Lung Immunization Prognostic Index;Glasgow prognostic score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Platelet-to-lymphocyte ratio;Platelet-to-lymphocyte ratio;Mean platelet volume; | — |
Countries
China
Contacts
Public ContactKongchunchu;You Meiyi
Hunan Provincial People's Hospital
Outcome results
None listed